Boston Scientific, Guidant Close The Deal Following FTC Approval
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific closed its $28 bil. acquisition of Guidant on April 21, one day after the Federal Trade Commission approved the deal - the largest medical device acquisition in history